ARISE Plus organised a third Workshop on ASEAN Pharmaceutical Regulatory Policy (APRP) and the associated ASEAN Pharmaceutical Regulatory Framework (APRF). The virtual event held on August 4th and 5th 2021, brought representatives from the ASEAN Pharmaceutical Products Working Group (PPWG) and ASEAN Health Cluster 3 (AHC 3) together to continue deliberations on the text of an ASEAN Pharmaceutical Regulatory Policy (APRP) and on the outline of the associated ASEAN Pharmaceutical Regulatory Framework( APRF). Officials from ASEAN Member States representing pharmaceutical regulators health officials made significant progress following up from the second workshop, held on June 7th & 8th 2021.
The workshop participants achieved substantial consensus towards finalising the text of an ASEAN Pharmaceutical Regulatory Policy (APRP) and are expected to finalise the draft upon resolution of one remaining article. It is planned to seek endorsement of ASEAN Senior Officials of the Economic and Health Development divisions as soon as the PPWG and AHC 3 resolve concerns on the remaining Article. In addition substantial consensus was also reached, through the deliberations on the ASEAN Pharmaceutical Regulatory Framework (APRF) and there was agreement that a final draft would be available by end of 2021 for Member States internal review.
For more information please visit News on Workshop on the ASEAN Pharmaceutical Regulatory Policy and the ASEAN Pharmaceutical Regulatory Framework (APRP and APRF)
